亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欣喜的冥王星完成签到,获得积分10
16秒前
22秒前
Li发布了新的文献求助10
28秒前
今天发CNS了嘛完成签到,获得积分10
30秒前
zLin发布了新的文献求助10
49秒前
6682完成签到,获得积分10
55秒前
充电宝应助狂野从蕾采纳,获得10
1分钟前
研友_VZG7GZ应助科研通管家采纳,获得10
1分钟前
嘻嘻哈哈应助科研通管家采纳,获得10
1分钟前
嘻嘻哈哈应助科研通管家采纳,获得10
1分钟前
1分钟前
嘻嘻哈哈应助科研通管家采纳,获得10
1分钟前
彭于晏应助科研通管家采纳,获得10
1分钟前
wanci应助活力冰巧采纳,获得30
2分钟前
hebnkygzs完成签到 ,获得积分10
2分钟前
2分钟前
Jasper应助伏远梦采纳,获得10
3分钟前
奥特超曼完成签到,获得积分0
3分钟前
3分钟前
3分钟前
3分钟前
GingerF应助zLin采纳,获得50
3分钟前
伏远梦发布了新的文献求助10
3分钟前
3分钟前
完美世界应助科研通管家采纳,获得10
3分钟前
桐桐应助科研通管家采纳,获得10
3分钟前
狂野从蕾发布了新的文献求助10
3分钟前
大熊完成签到 ,获得积分10
3分钟前
海边看日出完成签到,获得积分10
3分钟前
4分钟前
科研通AI6.3应助小椰汁采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
Echopotter完成签到,获得积分10
4分钟前
5分钟前
zLin发布了新的文献求助10
5分钟前
zLin发布了新的文献求助10
5分钟前
嘻嘻哈哈应助科研通管家采纳,获得10
5分钟前
zLin发布了新的文献求助30
5分钟前
高分求助中
Adhesion Science: Principles & Practice 1234
Signals, Systems, and Signal Processing 610
Burger's Medicinal Chemistry and Drug Discovery 400
A Step-by-Step Guide to Qualitative Data Coding 2nd Edition 400
Impact of Storage Orientation and Duration on Prefilled Syringe Performance: Break-Loose and Glide Forces, and Injection Time Across Multiple Time Points 360
Programming for Chemical Engineers Using C, C++, and MATLAB 300
Upland Kenya wild flowers and ferns: a flora of the flowers, ferns, grasses, and sedges of highland Kenya 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6659572
求助须知:如何正确求助?哪些是违规求助? 8410946
关于积分的说明 17982420
捐赠科研通 5860615
什么是DOI,文献DOI怎么找? 2973894
邀请新用户注册赠送积分活动 1949676
关于科研通互助平台的介绍 1873506